Aysegul Bilen

Aysegul Bilen

Auto-generated profile, based on publicly available information

Aysegul Bilen

Department of Pain Medicine, Prof. Dr. Cemil Tascioglu City Hospital, 34384 Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2025 in Hernia
Verified
Journal Article
Closed access
PDF file
HFHatice Feyizi
Hatice Feyizi
ABAyşegül Bilen
Ayşegül Bilen
RKrasim onur Karaoglu
rasim onur Karaoglu

17 June 2026 in Reports
Verified
Journal Article
Open access
PDF file
GYGursan Gunes Yenidogan
Gursan Gunes Yenidogan
NYNagihan Duran Yakar
Nagihan Duran Yakar
EAEnise Alioglu
Enise Alioglu
SGSalim Taner Gözükızıl
Salim Taner Gözükızıl
ABAysegul Bilen
Aysegul Bilen
Objectives: To evaluate the clinical impact and treatment adaptations during the immediate-release oxycodone hydrochloride shortage. Methods: This retrospective, observational study was conducted during the oxycodone shortage period (May 2024–March 2025) in patients with cancer pain. Pain intensity was assessed using the Numerical Rating Scale (NRS) at baseline (prior to switching, while receiving oxycodone) and at follow-up (after switching to alternative analgesics). Changes in pain intensity were evaluated using within-patient differences (ΔNRS), with clinically meaningful worsening defined as an increase of ≥2 points. Descriptive and inferential statistics were used to summarize patient characteristics and outcomes. Results: Of 300 patients screened, 55 met inclusion criteria (mean age 65.2 ± 11.0 years; 63.6% male). Pain intensity increased significantly following treatment modification during the period of oxycodone unavailability, with mean NRS scores rising from 4.3 ± 1.7 to 5.9 ± 2.5 (p < 0.001). The mean ΔNRS was +1.56 (95% CI 0.79–2.34), with clinically meaningful worsening observed in 36 patients (65.5%). No statistically significant association was observed between substitute analgesic type and clinically meaningful worsening (p = 0.11). Conclusions: The oxycodone shortage was associated with worsened pain control and increased need for treatment modifications in cancer patients, highlighting the importance of uninterrupted access to essential opioids.